ILLUMINATE-A, a phase 3 study of lumasiran, an investigational RNAi therapeutic, in children and adults with primary hyperoxaluria type 1 (PH1)

Garrelfs, S; Frishberg, Y; Hulton, S; Koren, M; O'Riordan, W; Cochat, P; Deschenes, G; Shasha-Lavsky, H; Saland, J; van't Hoff, W; Fuster, DG; Magen, D; Moochhala, S; Schalk, G; Simkova, E; Groothoff, J; Sas, D; Meliambro, K; Lu, JD; Garg, P; Gansner, J; McGregor, T; Lieske, J

SWISS MEDICAL WEEKLY, 2020; (): 8S

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索